Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells

Urologia Internationalis

Volumn 67, Issue 3, 2001, Pages 216-223

  Suzuki, Satoshi ^a   Tadakuma, Takushi ^a   Kunitomi, Michito ^a   Takayama, Eiji ^a   Sato, Masaki ^a   Asano, Tomohiko ^a   Nakamura, Hiroshi ^a   Hayakawa, Masamichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Gene therapy; Herpes simplex virus thymidine kinase ganciclovir; Liposome; Prostate cancer; Prostate specific antigen promoter enhancer

Indexed keywords

ANDROGEN; DRUG CARRIER; GANCICLOVIR; LIPOSOME; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE PROPIONATE; THYMIDINE KINASE;

ARTICLE; BLADDER CANCER; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE THERAPY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MALE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER;

GANCICLOVIR; GENE THERAPY; HUMANS; LIPOSOMES; MALE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0035743432     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050991     Document Type: Article

References (31)

1. International trends and patterns of prostate cancer incidence and mortality
2. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer
3. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
4. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
5. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
6. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
7. Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
8. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer cells
9. Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
10. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer
11. Transfer of genes to humans: Early lessons and obstacles to success
12. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer
13. Prostate-specific antigen expression is regulated by an upstream enhancer
14. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
15. A simple phase-extraction assay for chloramphenicol acyltransferase activity
16. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter
17. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
18. Defining a functional androgen responsive element in the 5′ far upstream flanking region of the prostate-specific antigen gene
19. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen
20. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients
21. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer
22. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
23. In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors
24. Transfecting well-differentiated prostatic cancer cell line LNCaP
25. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
26. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
27. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody
28. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
29. Expression of the prostate-specific membrane antigen
30. Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
31. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium